Entellus Medical (ENTL) Misses Q4 EPS by 6c

Entellus Medical (NASDAQ: ENTL) reported Q4 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $21.7 million versus the consensus estimate of $21.44 million.

GUIDANCE:

Entellus Medical sees Q1 2017 revenue of $19-20 million, versus the consensus of $20.1 million.

Sees FY 2017 revenues of $86-90 million versus consensus of $90.5 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Movano (MOVE) Misses Q2 EPS by 195c